|
|
|||
Citrullinemia type I (CTLN1) is an autosomal recessive disorder resulting from deficiency of the enzyme argininosuccinate synthase (ASS), the third step in the urea cycle, in which citrulline is condensed with aspartate to form arginosuccinic acid As with other urea cycle disorders, the age of presentation can vary, however the most common presentation is in the neonatal period. Affected infants become hyperammonemic and may experience vomiting, refusal to eat, progressive lethargy, and coma. Other than the acute neonatal form (the "classic" form), there is a milder late-onset form, and a rarely reported adult form . The ASS gene is localized to chromosome 9q34.1 and consists of 16 exons of which 14 are coding exons. Sequence analysis of the coding region of the ASS gene is available on a clinical basis at the Medical Genetics Laboratories at Baylor College of Medicine. Reasons for Referral:
Testing Methodology:Full Sequencing: A PCR-based assay is used to amplify all 16 exons of the ASS gene. Direct sequencing of amplification products is performed in both the forward and reverse directions using automated fluorescence dideoxy sequencing methods. Sensitivity:
Clinical: Approximately
90%
Specimen Requirements:Blood for DNA: EDTA
(purple-top) tubes: Adult/Child: Minimum 6-14 cc Turnaround Time:Index: 4
weeks CPT Codes and Prices:Index: 83904X30, 83912, 83909x30,
83898x15, 83894, 83891 References:1. Beaudet AL, O'Brien WE, Bock HG,
Freytag SO, Su TS. (1986) The human argininosuccinate synthetase locus
and citrullinemia. Adv. Hum. Genet. 15: 161-196, 291-292. Shipping InformationForms: >> Gene
Sequencing Requisition Test Codes:Index: 6180 |